Moving into a new era—SCIE coverage is the next rung on the ladder for Genes&Diseases

作     者：T.-C.He MD. PhD 

作者机构：The University of Chicago Medical CenterMolecular Oncology Laboratory/Dept of Orthopaedic Surgery5841 South Maryland Avenue.MC 3079ChicagoIL60637United States 

出 版 物：《Genes & Diseases》 (基因与疾病（英文）)

年 卷 期：2019年第6卷第4期

页      面：327-327页

核心收录：

学科分类：0710[理学-生物学] 1205[管理学-图书情报与档案管理] 12[管理学] 120502[管理学-情报学] 

主　　题：Genes&Diseases Impact Factor Molecular Medicine Personalized Medicine SCI Translational Medicine 

摘      要：In a letter dated August 30,2019 from Marian Hollingsworth,Director of Publisher Relations for the Web of Science Group Clarivate Analytics,Philadelphia,PA,USA,we were informed that Genes&Diseases has been selected for Science Citation Index Expanded(SCIE)coverage in the Genetics&Heredity and Biochemistry&Molecular Biology categories of the Clarivate Analytics products and *** with Volume 4(1),2017,Genes&Diseases will be indexed and abstracted in Science Citation Index Expanded(SCIE,also known as SciSearch
),Journal Citation Reports/Science Edition,Current Contents
/Life Sciences,and Biological *** first release of the journal’s Impact Factor(IF)is anticipated in June 2020.